Actinium Ac 225 Vipivotide tetraxetan

DB23637InvestigationalSmall molecule

Actinium Ac 225 Vipivotide Tetraxetan is a small molecule drug. Actinium Ac 225 Vipivotide Tetraxetan is under investigation in clinical trial NCT07150715 (Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic...

Mechanism: Pharmacologically active on Glutamate carboxypeptidase 2
Curator reviewed
Code names: 225Ac-PSMA-617 · AAA817

Resolves to

Compound

UNIIAB6DQ43TKE

Targets

Q04609FOLH1

What you can answer from here — as of June 27, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Actinium Ac 225 Vipivotide tetraxetan, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account